UTHealth Houston researchers awarded $2M to uncover a nonaddictive diabetic neuropathic pain therapy as the opioid crisis still looms in the US
Written by: Sydney Lowther / September 19, 2025 A $2 million grant awarded to UTHealth Houston by the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health, will allow researchers to develop a safe…
An wins ASPET scientific achievement award
The American Society for Pharmacology and Experimental Therapeutics (ASPET) has named Zhiqiang An, PhD, professor and Robert A. Welch Distinguished University Chair in Chemistry and vice president of Drug Discovery, as the winner of its 2024 Scientific Achievement Award in Drug Discovery and Development. The…
Hancock’s Headlines: Texas Therapeutics Institute
When the COVID pandemic hit, the Texas Therapeutics Institute sprung into action to develop therapies for patients suffering from the virus. Not only have they developed drugs to help fight COVID, but they are also developing neurological drugs to help…
New antibody shows therapeutic effects in mice with Alzheimer’s disease (UTHealth Houston News)
Research led by senior author Zhiqiang An, PhD, professor and Robert A. Welch Distinguished University Chair in Chemistry at McGovern Medical School at UTHealth Houston, found that a tetra-variable domain antibody targeting the triggering receptor expressed on myeloid 2 (TREM2) –…